Free Trial

Jin Medical International (ZJYL) Competitors

Jin Medical International logo
$0.80 +0.01 (+1.27%)
As of 02:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ZJYL vs. AXGN, DCTH, TMCI, NPCE, CLPT, SMLR, NNOX, SMTI, STIM, and SNWV

Should you be buying Jin Medical International stock or one of its competitors? The main competitors of Jin Medical International include AxoGen (AXGN), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Semler Scientific (SMLR), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), Neuronetics (STIM), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry.

Jin Medical International vs.

Jin Medical International (NASDAQ:ZJYL) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation, community ranking and media sentiment.

AxoGen has a consensus price target of $22.20, suggesting a potential upside of 91.88%. Given AxoGen's stronger consensus rating and higher probable upside, analysts clearly believe AxoGen is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AxoGen
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Jin Medical International has a beta of 12.24, indicating that its stock price is 1,124% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500.

Jin Medical International has a net margin of 0.00% compared to AxoGen's net margin of -7.91%. Jin Medical International's return on equity of 0.00% beat AxoGen's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
AxoGen -7.91%-14.91%-7.49%

AxoGen received 458 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
Jin Medical InternationalN/AN/A
AxoGenOutperform Votes
458
72.93%
Underperform Votes
170
27.07%

Jin Medical International has higher earnings, but lower revenue than AxoGen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$23.50M5.26$3.68MN/AN/A
AxoGen$194.52M2.71-$21.72M-$0.15-77.13

80.3% of AxoGen shares are owned by institutional investors. 2.8% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, AxoGen had 10 more articles in the media than Jin Medical International. MarketBeat recorded 10 mentions for AxoGen and 0 mentions for Jin Medical International. AxoGen's average media sentiment score of 0.50 beat Jin Medical International's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media.

Company Overall Sentiment
Jin Medical International Neutral
AxoGen Neutral

Summary

AxoGen beats Jin Medical International on 9 of the 15 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

MetricJin Medical InternationalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$123.67M$9.70B$5.42B$8.48B
Dividend YieldN/A1.62%5.22%4.11%
P/E RatioN/A21.4026.8020.05
Price / Sales5.2666.68393.93116.47
Price / Cash31.4419.6738.2534.62
Price / Book4.395.226.864.61
Net Income$3.68M$284.66M$3.22B$248.19M
7 Day Performance24.25%1.54%6.81%2.97%
1 Month Performance-11.24%7.42%13.72%16.58%
1 Year Performance-72.47%-19.10%18.24%8.16%

Jin Medical International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
N/A$0.80
+1.3%
N/A-74.2%$125.24M$23.50M0.00245
AXGN
AxoGen
3.4241 of 5 stars
$11.39
+0.3%
$22.60
+98.4%
+86.6%$518.64M$187.34M-35.59450
DCTH
Delcath Systems
3.1205 of 5 stars
$14.45
-2.6%
$22.75
+57.4%
+123.8%$483.11M$37.21M-10.7060News Coverage
Positive News
TMCI
Treace Medical Concepts
2.3204 of 5 stars
$7.20
+5.6%
$10.16
+41.1%
+35.4%$452.81M$210.82M-7.27250Trending News
NPCE
NeuroPace
1.4895 of 5 stars
$13.37
+3.7%
$15.20
+13.7%
+125.4%$437.91M$79.91M-13.37170
CLPT
ClearPoint Neuro
1.7418 of 5 stars
$13.64
-3.3%
$25.00
+83.3%
+108.6%$381.65M$31.39M-19.77110Gap Down
SMLR
Semler Scientific
2.5738 of 5 stars
$34.84
+0.1%
$71.00
+103.8%
+78.4%$334.36M$56.29M7.10120Options Volume
Gap Up
High Trading Volume
NNOX
Nano-X Imaging
1.4558 of 5 stars
$5.56
+6.1%
$12.00
+115.8%
-43.7%$321.25M$11.28M-6.54190News Coverage
Upcoming Earnings
SMTI
Sanara MedTech
1.7872 of 5 stars
$34.37
+6.2%
$48.50
+41.1%
-4.6%$305.48M$86.67M-34.7260Earnings Report
Analyst Revision
High Trading Volume
STIM
Neuronetics
1.9412 of 5 stars
$4.14
-6.5%
$5.50
+32.9%
+69.6%$272.47M$74.89M-3.37180
SNWV
SANUWAVE Health
N/A$30.55
+1.5%
N/AN/A$261.17M$32.63M-6.7040

Related Companies and Tools


This page (NASDAQ:ZJYL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners